NGEN · Nervgen Pharma Corp.
Total shares sold short and not yet covered, reported to FINRA by broker-dealers twice a month. Each reading settles on the 15th and the last business day of the month and is published seven business days later — the next scheduled dates are listed at the top of the table. Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.
Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-07-15). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
|
2026-08-14
Scheduled
FINRA publishes Aug 25
|
— | — | — | — |
|
2026-07-31
Scheduled
FINRA publishes Aug 11
|
— | — | — | — |
| 2026-07-15 | 4,512,061 | 4,055,299 | +456,762 | 5.23 |
| 2026-06-30 | 4,055,299 | 3,452,036 | +603,263 | 4.43 |
| 2026-06-15 | 3,452,036 | 3,085,310 | +366,726 | 3.97 |
| 2026-05-29 | 3,085,310 | 1,563,015 | +1,522,295 | 1.27 |
| 2026-05-15 | 1,563,015 | 1,469,644 | +93,371 | 9.41 |
| 2026-04-30 | 1,469,644 | 1,274,764 | +194,880 | 8.58 |
| 2026-04-15 | 1,274,764 | 1,425,061 | -150,297 | 3.90 |
| 2026-03-31 | 1,425,061 | 1,350,054 | +75,007 | 11.33 |
| 2026-03-13 | 1,350,054 | 1,309,036 | +41,018 | 12.17 |
| 2026-02-27 | 1,309,036 | 1,314,789 | -5,753 | 14.25 |
| 2026-02-13 | 1,314,789 | 1,267,781 | +47,008 | 9.81 |
| 2026-01-30 | 1,267,781 | 1,219,022 | +48,759 | 7.66 |
| 2026-01-15 | 1,219,022 | 1,192,080 | +26,942 | 4.98 |